J Clin Med Res
Novel kappa opioid receptor antagonist navacaprant significantly reduces depression symptoms: Phase II study
Development of κ opioid receptor antagonists. | Semantic Scholar
Kappa-opioid receptor-dependent changes in dopamine and anxiety-like or approach-avoidance behavior occur differentially across the nucleus accumbens shell rostro-caudal axis - ScienceDirect
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
κ-opioid receptor/dynorphin system: genetic and pharmacotherapeutic implications for addiction: Trends in Neurosciences
Schematic representation of dynorphin/kappa opioid receptor system... | Download Scientific Diagram
In major depression, increased kappa and mu opioid receptor levels are associated with immune activation | Acta Neuropsychiatrica | Cambridge Core
Chronic Kappa opioid receptor activation modulates NR2B: Implication in treatment resistant depression | Scientific Reports
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Psychoactives | Free Full-Text | The Role of the Dynorphin/Kappa Opioid Receptor System in the Actions of Alcohol
Peripheral Kappa Opioid Receptor Signaling Takes on a Central Role - ScienceDirect
Can Kappa and Alpha-2 Agonist Agents Treat Opioid-Induced Ventilatory Depression Risk While Preserving Analgesic Effects?
Major Depressive Disorder and Kappa Opioid Receptor
Kappa opioid receptor (KOR) modulation of dopamine in the cortex and... | Download Scientific Diagram
The Role of Dynorphin and the Kappa Opioid Receptor in Schizophrenia and Major Depressive Disorder: A Translational Approach | SpringerLink
Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain | Journal of Neuroscience
Dynorphin/kappa-opioid receptor control of dopamine dynamics: Implications for negative affective states and psychiatric disorders - ScienceDirect
Project 1: Therapeutic Potential of Kappa Opioid Receptor Antagonists in the Treatment of Depression (Chavkin) | Conte Center
A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists. - Abstract - Europe PMC
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Chronic Kappa opioid receptor activation modulates NR2B: Implication in treatment resistant depression – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science
Constitutive activation of kappa opioid receptors at ventral tegmental area inhibitory synapses following acute stress | eLife
Opioids in cancer: The κ‑opioid receptor (Review)
